Biomarkers of inflammation, including inflammatory cytokines and the acute-phase reactant C-reactive protein (CRP), are reliably increased in a subset of patients with depression, anxiety disorders and post-traumatic stress disorder (PTSD). Administration of innate immune stimuli to laboratory subjects and the associated release of inflammatory cytokines has been shown to affect brain regions involved in fear, anxiety and emotional processing such as the amygdala. However, the role of inflammation in altered circuitry involving amygdala and other brain regions and its subsequent contribution to symptom severity in depression, anxiety disorders and PTSD is only beginning to be explored. Herein, medically-stable, currently unmedicated outpatients with a primary diagnosis of major depressive disorder (MDD; n = 48) underwent resting-state functional MRI (rfMRI) to determine whether altered connectivity between the amygdala and whole brain was observed in a subset of patients with high inflammation and symptoms of anxiety. Whole-brain, voxel-wise functional connectivity analysis of the right and left amygdala as a function of inflammation (plasma CRP concentrations) revealed that increased CRP predicted decreased functional connectivity between right amygdala and left ventromedial prefrontal cortex (vmPFC) (corrected p < 0.05). Amygdala-vmPFC connectivity was, in turn, negatively correlated with symptoms of anxiety (r = −0.33, df = 46, p = 0.022). In exploratory analyses, relationships between low amygdala-vmPFC connectivity and high anxiety were only observed in patients with a secondary diagnosis of an anxiety disorder or PTSD (r = −0.54 to −0.87, p < 0.05). More work is needed to understand the role of inflammation and its effects on amygdala-vmPFC circuitry and symptoms of anxiety in MDD patients with comorbid anxiety disorders or PTSD.
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Introduction
Inflammation, as measured by inflammatory cytokines and the acute-phase reactant C-reactive protein (CRP), is reliably increased in patients with depression, anxiety disorders and post-traumatic stress disorder (PTSD), and is thought to contribute to symptom severity (Felger, 2017) . Relevant to the effects of inflammation on the brain, numerous laboratories have consistently reported that administration of cytokines or inflammatory stimuli to humans and laboratory animals preferentially affects cortical-basal ganglia reward and motor circuits (Capuron et al., 2012; Eisenberger et al., 2010; Harrison et al., 2015) , as well as regions involved in fear, anxiety and emotional processing such as the amygdala (Inagaki et al., 2012; Harrison et al., 2009a,b) . For example, administration of endotoxin or typhoid vaccination to healthy persons has been shown to induce symptoms of anxiety, increase amygdala neural activation, and reduce functional connectivity between the amygdala and ventromedial prefrontal cortex (vmPFC), all of which correlated with the release of inflammatory cytokines in peripheral blood (Inagaki et al., 2012; Harrison et al., 2009a,b; Lasselin et al., 2016) . Additionally, and in regard to sensitivity of the neural
